Cargando…
Allogeneic hematopoietic cell transplantation, the microbiome, and graft-versus-host disease
Many patients with hematological malignancies, such as acute myeloid leukemia, receive an allogeneic hematopoietic cell transplantation (HCT) to cure their underlying condition. Allogeneic HCT recipients are exposed to various elements during the pre-, peri- and post-transplant period that can disru...
Autores principales: | van Lier, Yannouck F., Vos, Jaël, Blom, Bianca, Hazenberg, Mette D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980553/ https://www.ncbi.nlm.nih.gov/pubmed/36794370 http://dx.doi.org/10.1080/19490976.2023.2178805 |
Ejemplares similares
-
The post-hematopoietic cell transplantation microbiome: relationships with transplant outcome and potential therapeutic targets
por: van Lier, Yannouck F., et al.
Publicado: (2021) -
Methotrexate for the Treatment of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
por: Nassar, Amr, et al.
Publicado: (2014) -
Natural Killer Cells in Graft-versus-Host-Disease after Allogeneic Hematopoietic Cell Transplantation
por: Simonetta, Federico, et al.
Publicado: (2017) -
Immune Reconstitution and Graft-Versus-Host Reactions in Rat Models of Allogeneic Hematopoietic Cell Transplantation
por: Zinöcker, Severin, et al.
Publicado: (2012) -
Graft conditioning with fluticasone propionate reduces graft‐versus‐host disease upon allogeneic hematopoietic cell transplantation in mice
por: Varady, Erika S, et al.
Publicado: (2023)